Abstract

Objective: The tcdC gene of C. difficile negatively regulates the production of toxins A and B. Mutations within this gene may result in loss of the negative regulatory role, potentially leading to hyperproduction of toxins and increased virulence. This hypervirulent strain caused an epidemic of C. difficile-associated disease in Quebec in 2002 and has been seen in increasing numbers in the western provinces, including BC. The objective of this study was to produce a baseline of the molecular and phenotypic profile of strains from participating centres to complement future infection control surveillance programs for C. difficile infection in BC. Methods: Over a one month period in March 2008, all stool specimens positive for C. difficile testing were cultured at participating laboratories or forwarded to the reference laboratory (BCCDC) for culture. Methods were standardized across participating laboratories. C. difficile was identified by colony morphology, Gram-stain, aerotolerance and C. difficile latex agglutination kit. The presence of the tcdC gene deletion was determined for each isolate using fragment analysis PCR. A fingerprint pattern was generated using pulsed-field gel electrophoresis (PFGE) and assigned PFGE pattern numbers and NAP type using the Canadian C. difficile database. Results: The total number of specimens received over the month of March 2008 from all participating sites was 414. Of these, 368 were culture confirmed cases of C. difficile. The tcdC gene mutation was detected in 189 (51.4%) isolates and the remaining 179 (48.6%) were wildtype strains with no mutation. Of those detecting a mutation, 145 (76.7%) displayed a mutation at ( 18)( 1) in the tcdC gene, associated with NAP1 PFGE designation and the remaining 29 (15.3%) showed a mutation other than at the ( 18)( 1) region. 156 (42.4%) of the total cases matched the NAP1 PFGE designation. Less common were PFGE patterns with NAP2 designation (9.5%) and NAP4 designation (7.8%). Conclusions: The prevalence of the NAP1 strain of C. difficile in the province of BC was 42% for March 2008. Of the C. difficile isolates recovered, the majority contained mutation at ( 18)( 1), with 15.3% exhibiting mutations at other sites within PaLoc. This study provides a baseline for infection control and public health functions in BC. O30 The use of a multi locus sequence typing scheme to characterize Canadian isolates of Corynebacterium diphtheriae K. Bernard1 *, S. Schindle2, T. Burdz1, D. Wiebe1, A. Reimer, C. Dowson3, F. Bolt3, A. Baldwin3. 1National Microbiology Laboratory, Winnipeg, Canada, 2University of Manitoba, Winnipeg, Canada, 3University of Warwick, Warwick, United Kingdom

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.